Geneos Wealth Management Inc. Purchases 593 Shares of Exelon Corporation $EXC

Geneos Wealth Management Inc. grew its stake in Exelon Corporation (NASDAQ:EXC) by 14.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,570 shares of the company’s stock after buying an additional 593 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Exelon were worth $211,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Exelon by 0.5% in the first quarter. Vanguard Group Inc. now owns 127,917,037 shares of the company’s stock valued at $5,894,417,000 after buying an additional 581,686 shares during the period. Deutsche Bank AG boosted its holdings in shares of Exelon by 11.6% in the first quarter. Deutsche Bank AG now owns 19,077,520 shares of the company’s stock valued at $879,092,000 after buying an additional 1,988,212 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of Exelon by 0.7% in the first quarter. Massachusetts Financial Services Co. MA now owns 15,837,173 shares of the company’s stock valued at $729,777,000 after buying an additional 106,917 shares during the period. Invesco Ltd. boosted its holdings in shares of Exelon by 0.6% in the first quarter. Invesco Ltd. now owns 13,802,263 shares of the company’s stock valued at $636,008,000 after buying an additional 83,518 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Exelon by 43.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock valued at $483,525,000 after buying an additional 3,878,687 shares during the period. Institutional investors and hedge funds own 80.92% of the company’s stock.

Exelon Stock Performance

NASDAQ EXC opened at $42.73 on Wednesday. The firm has a 50-day moving average of $44.00 and a 200-day moving average of $44.19. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. The stock has a market cap of $43.16 billion, a PE ratio of 16.25, a P/E/G ratio of 2.55 and a beta of 0.41. Exelon Corporation has a 52-week low of $35.94 and a 52-week high of $48.11.

Exelon (NASDAQ:EXC) last posted its earnings results on Thursday, July 31st. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.02. The company had revenue of $5.43 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. Exelon’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.47 EPS. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. On average, sell-side analysts anticipate that Exelon Corporation will post 2.64 EPS for the current year.

Exelon Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Monday, August 11th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date was Monday, August 11th. Exelon’s dividend payout ratio (DPR) is currently 60.84%.

Analysts Set New Price Targets

EXC has been the subject of several research analyst reports. KeyCorp reduced their price target on shares of Exelon from $39.00 to $37.00 and set an “underweight” rating for the company in a report on Wednesday, July 16th. Morgan Stanley reiterated an “outperform” rating on shares of Exelon in a report on Thursday, August 21st. Finally, UBS Group restated a “neutral” rating and set a $48.00 target price (up previously from $47.00) on shares of Exelon in a report on Friday, July 11th. Five equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $47.20.

Exelon Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.